Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
RedHill Biopharma Ltd. See All Filings	D	2024-02-05 08:00:16 UTC
Amount To Be Raised $10,000,000 Associated Brokers / Dealers H.C. Wainwright & Co., LLC CIK Number 0001553846 Filed Document 0001178913-24-000357 Exclusions or Exemptions 506b Accepted Date 2024-02-05 08:00:16 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business ISRAEL Revenue or Assets $$5,000,001 - $25,000,000 Type of Security Equity
RedHill Biopharma Ltd. See All Filings	D	2023-10-12 16:05:20 UTC
Amount To Be Raised $4,043,808 Associated Brokers / Dealers H.C. Wainwright & Co., LLC CIK Number 0001553846 Filed Document 0001178913-23-003313 Exclusions or Exemptions 506b Accepted Date 2023-10-12 16:05:20 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business ISRAEL Revenue or Assets $$25,000,001 - $100,000,000 Type of Security Equity
RedHill Biopharma Ltd. See All Filings	D	2023-08-07 16:05:22 UTC
Amount To Be Raised $2,700,000 Associated Brokers / Dealers H.C. Wainwright & Co., LLC CIK Number 0001553846 Filed Document 0001178913-23-002730 Exclusions or Exemptions 506b Accepted Date 2023-08-07 16:05:22 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business ISRAEL Revenue or Assets $$25,000,001 - $100,000,000 Type of Security Equity
RedHill Biopharma Ltd. See All Filings	D	2021-11-22 16:59:53 UTC
Amount To Be Raised $10,000,000 Associated Brokers / Dealers Network 1 Financial Securities, Inc. and Nexpedia Holdings Co., Ltd CIK Number 0001553846 Filed Document 0001178913-21-003671 Exclusions or Exemptions 506b Accepted Date 2021-11-22 16:59:53 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business ISRAEL Revenue or Assets $$25,000,001 - $100,000,000 Type of Security Equity
RedHill Biopharma Ltd. See All Filings	D	2019-11-06 14:34:35 UTC
Amount To Be Raised $48,300,000 Associated Brokers / Dealers N/A CIK Number 0001553846 Filed Document 0001553846-19-000003 Exclusions or Exemptions 506b Accepted Date 2019-11-06 14:34:35 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business ISRAEL Revenue or Assets $$5,000,001 - $25,000,000 Type of Security Equity
RedHill Biopharma Ltd. See All Filings	D	2014-01-15 00:00:00 UTC
Amount To Be Raised $2,500,020 Associated Brokers / Dealers Roth Capital Partners, LLC and Stifel, Nicolaus & Company, Incorporated CIK Number 0001553846 Filed Document 0001144204-14-002372 Exclusions or Exemptions 506b Accepted Date 2014-01-15 00:00:00 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business ISRAEL Revenue or Assets $$1 - $1,000,000 Type of Security Equity